: Supthe way they replicate.
35p PSIϩ shows increased protease resistance and is Little is known about additional proteins participating found mostly in an aggregated state (Patino et al., 1996 ; in prion conversion in mammals. In yeast, the propaga- Paushkin et al., 1996) . An increased protease resistance tion of the [PSI ϩ ] prion determinant critically depends was also shown for Ure2p from [URE3] cells. These on the chaperone protein Hsp104 (Hsp104p). This deresults indicate that the formation of high-molecular pendence is somewhat paradoxical: both the lack and weight aggregates and protease resistance are characthe excess of Hsp104p eliminate [PSI ϩ ]. Below we preteristic, rather than fortuitous, properties of different sent a model explaining the role of Hsp104p in propagaprions. tion of the prion structure of the yeast Sup35 protein
Only the amino-terminal fragment of 113 amino acids (Sup35p). This model may have implications for the re-(N domain) is required for Sup35p aggregation and lated mammalian diseases.
[PSI ϩ ] propagation (Paushkin et al., 1996) . The carboxyThe Prion Concept terminal domain of amino acids 254-685 is responsible The prion concept originates from studies of transmissifor the Sup35p function in translation termination. In ble spongiform encephalopathies, such as sheep scrapie [PSI ϩ ] cells, Sup35p aggregates via its N domain, which and human kuru and Creutzfeldt-Jacob disease (CJD) reduces the efficiency of translation termination and (for review, see Prusiner, 1991; Horwich and Weissman, causes the nonsense-suppressor phenotype. Thus, the 1997). Numerous lines of evidence indicate that the in-N domain can serve in a [PSI ϩ ]-dependent regulation of fectious agents causing these diseases are proteins the efficiency of termination. Ure2p structurally resemrather than nucleic acid. To explain the protein-only inbles Sup35p, being composed of an amino-terminal fectivity, it was proposed that the infectious protein is
[URE3]-inducing domain and a carboxy-terminal funcable to exist in two different forms and that the infectious tional domain. form can catalyze the conversion of the normal form
The prion-like conversion of Sup35p was reproduced into the infectious one. Such protein was purified by S.
in vitro, and it was demonstrated that highly purified Prusiner and coworkers in 1982 and named prion protein Sup35p PSIϩ is able to initiate such conversion efficiently or PrP. The normal form of PrP (PrP C ) represents a mem- (Paushkin et al., 1997) . Thus, in full accordance with brane protein, constitutively expressed by host cells, the prion hypothesis, the information about the Sup35p and the infectious form (PrP Sc ) can catalyze the converaltered state is stored solely within Sup35p PSIϩ . The in sion of PrP C to PrP Sc in full accordance with the above vitro conversion of Sup35p proceeded much more efficoncept. Apart from the infectivity, PrP Sc differs from ciently than that of PrP in analogous experiments PrP C physically by high protease resistance and propen- (Caughey et al., 1995) . This allowed a chain of sequential sity to aggregate. This difference results from conformaconversion reactions to be performed using an aliquot tional alteration of PrP Sc , rather than any covalent modifiof the previous reaction to start the next one, thus modcations: PrP Sc is rich in ␤ sheet, while PrP C is almost eling in vitro the continuous propagation of the Sup35p devoid of it. prion state.
Yeast Prions
Of most importance for the present consideration The analogy with prions was used to explain the unusual were the observations that purified recombinant Sup35p genetic properties of two yeast determinants, [PSI ϩ ] and can assemble into uniform fibers (Glover et al., 1997; [URE3] (for review, see Lindquist, 1997) . These determi- King et al., 1997; DePace et al., 1998) . These fibers were nants show non-Mendelian, cytoplasmic inheritance. similar to amyloid fibers, showing an altered Sup35p However, unlike other cytoplasmic factors, such as miconformation, rich in ␤ sheet, and an ability to bind tochondrial genes and viruses, they may be "cured" or Congo red dye. These findings underscore the relationeliminated during growth in the presence of low concenship of Sup35p to both prions and amyloidogenic protrations of protein denaturant guanidine hydrochloride teins, and thus support the idea that the prion and amyloid phenomena are related. and can reappear without introduction of new DNA,
Amyloid Fibers and Their Similarity with Prions
would be capable of precise self-reproduction. In the polymerization model, any of the possible alternative Amyloids are insoluble fibrous protein deposits that accumulate in some human diseases, or amyloidoses (for conformations can be stabilized by intermolecular interactions within the polymer. Besides, in this model the review, see Kelly, 1996) . Although different amyloidogenic proteins are structurally and functionally unreexistence of many different tertiary conformations is not strictly required: the strain difference may also result lated, the amyloid fibrils formed by them are very similar, being about 10 nm in width and having a characteristic from different kinds of quaternary assembly of prion molecules into fibers. The possibility of different kinds cross-␤ structure, in which the individual ␤ strands are oriented perpendicular to the axis of the fibril. Amyloids of prion proteins packing into polymers was demonstrated in the experiments on Sup35p self-assembly in can bind Congo red, giving a characteristic birefringence in polarized light.
vitro (Glover et al., 1997) . The fibers with apparently different structure were observed even within a single There are a number of significant similarities between the prion and amyloid phenomena. Prion diseases are Sup35p preparation. Notably, transitions between different structural types were never observed within a often accompanied by fibrous PrP deposits, which show the properties of amyloids, an increased ␤ sheet content single fiber, which demonstrates the stable propagation of different structural characteristics along the length of and the ability to bind Congo red. In turn, amyloid fibers conform to the criteria for prion protein: the normal and the fibers. There are also some data that do not fit well with the polymer forms of amyloidogenic proteins are clearly different, and the latter can promote the polymerization of polymerization model for Sup35p in its original, noncatalytic version from Jarrett and Lansbury. They prenormal proteins into amyloid fibers.
Structure of Prion Aggregates
dicted that the rate of fibril nucleation should be highly dependent on the monomer concentration, being proThere are two different models for the process of prion conversion, which also represent two different apportional to the (N Ϫ 1)th power, where N is the number of monomers in the nuclei. A similar high degree of proaches to the structure of prions. The heterodimer or template-assistance model assumes that infectious concentration dependence was observed in the polymerization on nonamyloid fibrils of sickle-cell hemogloPrP Sc can exist as a monomer and such a monomer catalyzes the prion rearrangement of a PrP C molecule bin. However, the nucleation of Sup35p fibrils showed only a first-order or even lower dependence on the through formation of a heterodimer complex. Then two PrP Sc molecules dissociate and can repeat the cycle, Sup35p concentration (Glover et al., 1997; DePace et al., 1998) . These data may be explained by the observawhile the PrP Sc aggregation is a secondary process, which is not essential for the prion conversion (Prusiner, tion of some metastable oligomeric Sup35p complexes at early stages of polymerization (Glover et al., 1997). 1991). The nucleated polymerization model is a universal model for the prion and amyloid formation, which conThese complexes may either represent "off-pathway" associations, and then the concentration of Sup35p mosiders prions and amyloid fibers as regular polymers or one-dimensional crystals that serve as nuclei for further nomers may be much lower and not proportional to its total concentration, or they may represent some interpolymerization (Jarrett and Lansbury, 1993) . The formation of nuclei is a rate-limiting step of the process, and mediates in the nucleation process. Thus, the kinetic data do not disprove the polymerization model, but sugthus the presence of preformed nuclei greatly accelerates polymerization. The conformational alteration of gest that the Sup35p nucleation is a more complicated process than anticipated by Jarrett and Lansbury and monomers may either occur spontaneously and then be fixed in polymer structure, as originally suggested by may thus support the alternative, catalytic variant of this model. Jarrett and Lansbury, or, alternately, be directly catalyzed by polymer at the moment of accretion (Horwich The ability of Sup35p to assemble into amyloid-like fibers in vitro argues strongly in favor of the existence and Weissman, 1997). In both noncatalytic and catalytic variants of this model, the arrangement of prion moleof a polymer structure of Sup35p PSIϩ in vivo. First, the amyloid formation by Sup35p occurred under a wide cules into ordered aggregates is a key characteristic of a prion state.
range of salt concentrations and pH, including those found within yeast cells. Second, the protein extracts Although at present it is difficult to choose in favor of one of these two models, it should be noted that the from [PSI ϩ ] cells were able to initiate the Sup35p polymerization in vitro (Glover et al., 1997) . Finally, the depolymerization model is in a better agreement with some sets of experimental data. For example, the scrapie creased ability of mutant Sup35p to support [PSI ϩ ] propagation correlated with the decreased rate of in vitro agent was always found in aggregated fractions and never isolated as soluble monomer. The experiments fibril formation by these proteins (DePace et al., 1998) . Taken together, the above arguments provide significant on in vitro prion conversion of either PrP or Sup35p also showed that the converting activity was only found in support for the filamentous structure of Sup35p PSIϩ aggregates in vivo. the fractions of aggregates (Caughey et al., 1995; Paushkin et al., 1997 PSIϩ aggregates into smaller pieces, which is necessary for their stable inheritance in cellular divisions (Paushkin et al., 1996) . The demonstration that Sup35p can form amyloid-like fibers in vitro suggests a similar fibrous structure for the Sup35p
PSIϩ aggregates in vivo. This provides additional support for the second model, which we will discuss further below. noted that the proposed mechanism of Hsp104p action (Paushkin et al., 1996) . This suggests that Hsp104p may is only applicable to filamentous aggregates and is unact on Sup35p
PSIϩ complexes in the same way as it acts likely to work in the case of globular aggregates, which on denatured protein aggregates. Probably, Sup35p PSIϩ could not be cut so easily into smaller pieces. aggregates show some properties of denatured protein,
The acceleration of fibril formation by fragmentation in contrast to other cellular macrostructures and microwas observed in several cases for both amyloid and nonfilaments not recognized by Hsp104p. The action of amyloid fibrils. For example, it was found that the polyHsp104p on Sup35p
PSIϩ fibers at any random position merization of purified Sup35p was dramatically accelerwould simply cut them into smaller pieces. This may ated simply by rotation of the samples during incubation occur through refolding of one or several Sup35p mole- (DePace et al., 1998) . The acceleration was explained cules to a soluble conformation at a particular site. The by shearing of the Sup35p fibrils by hydrodynamic forces. "destructive" function of Hsp104p toward Sup35p fibers This appears to be the most likely explanation, even may be balanced by their ability to grow by the accretion though such forces in a rotating tube should be fairly of soluble monomers. Overexpressed Hsp104p may dismild. rupt the balance and dissolve all Sup35p aggregates.
Hsp104p is the only chaperone capable of disaggreHowever, at moderate levels Hsp104p would only faciligating heat-denatured proteins in yeast (Parsell et al., tate the propagation and inheritance of prion aggregates 1994). Since Hsp104p is essential for the [PSI ϩ ] maintedue to the following considerations.
nance, one might assume that Hsp104p could be the First, since Sup35p filaments can grow only at their only or the most efficient enzyme capable of breaking ends, the overall polymerization rate is proportional to filamentous aggregates and that this function might not the number of these ends. The cuts by Hsp104p could be substituted by other cellular enzymes, such as other create new free ends, thus accelerating polymerization chaperones or proteases. (Figure 1) .
Implications for Higher Organisms Second, it is possible that the growth surfaces of By analogy with the yeast model, the fragmentation of the aggregate would become blocked due to fortuitous prion and amyloid polymers performed by Hsp104p hointeractions with other proteins or proteolytic fragments mologs or other factors should influence their propagaof the same protein. The polymerization would be contion and accumulation. The fragmentation might acceltinued only if new growth faces would be created by erate accumulation of prion and amyloid aggregates, Hsp104p cleavage at internal sites of the fiber.
but it might also serve to dissolve these aggregates if Third, the cleavage of Sup35p aggregates by Hsp104p the fragmenting activity is high enough. The level of would be required for the inheritance of aggregates in chaperone activity could control the appearance of amyfrequently dividing yeast cells. Without it the aggregates loids and explain their age-dependent onset. The fragcould grow in size, but their number would not increase, mentation of prions would be essential for their transwhich would eventually preclude their segregation to missibility, but would not be so critical for amyloid daughter cells in cellular divisions.
polymers, which are not transmissible and can appear Thus, although Hsp104p is not essential for the Sup35p prion-like conversion, it could increase the overall Sup35p by nucleation.
in mammals as well. At least one might expect different levels of chaperone fragmenting activity and probably even different factors causing fragmentation in intraand extracellular compartments. Thus, in terms of the type and levels of fragmenting activity the best analogy with yeast prions may be found in intracellular amyloid diseases, related to the expansion of polyglutamine tracts in some human proteins. These diseases are accompanied by neuronal nuclear inclusions, formed by the respective polyglutamine proteins. The expanded polyglutamine domain of one such protein, huntingtin, was shown to form amyloid fibrils in vitro (Scherzinger et al., 1997) . The abundance of glutamine and the related amino acid asparagine is also a characteristic feature of prion domains of Sup35p and Ure2p of S. cerevisiae. This feature is common for Sup35p from different yeast species and fungi, although not from higher eukaryotes. The importance of these residues was further demonstrated by the finding that the mutations which interfere with the prion properties of Sup35p fall within a short amino-terminal fragment, which is rich in Gln and Asn (DePace et al., 1998) . The yeast prions and polyglutamine proteins might be considered as a single structural class, in contrast to other amyloidogenic proteins, which are not abundant in Gln and Asn. These similarities suggest that chaperones like Hsp104p might play an important role in diseases associated with expanded polyglutamine tracts.
